Read this company snapshot
Daily valuation snapshot
Burning Rock Biotech Limited American Depositary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $15.49
- Market capitalization (USD)
- $1,009,805.49
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.01
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research BNR in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research BNR in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its key products include OncoScreen Focus, a multi-gene tumor mutation co-detection test kit for non-small cell lung cancer (NSCLC) patients; OncoScreen Plus, a pan-cancer test for tissue samples; OncoCompass Plus, a corresponding test for liquid biopsy samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; and ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers. The company also provides CanCatch, a pre-operative ctDNA detection and post-operative minimal residual disease calling for relapsed patients; OncoMaster, an automatic NGS data analysis and report interpretation machine; as well as Magnis BR-customized version of its key products. In addition, it engages in the facilitation of laboratory equipment sales and sales of reagent kits. The company has a development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, IMPACT Therapeutics, Boehringer Ingelheim, and Merck KGaA. Burning Rock Biotech Limited was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing BNR with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $15.49 |
| Market capitalization (USD) | $1,009,805.49 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.01 |
No matching rows. Clear the filter to see all records.
Read BNR's valuation metrics
Company size
Burning Rock Biotech Limited American Depositary Shares's recorded market capitalization is $1,009,805.49. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
BNR's recorded price-to-book ratio is 0.01. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Burning Rock Biotech Limited American Depositary Shares with Aurora
Use the snapshot above to ask a specific question about BNR. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow BNR's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.